LP
ROIV icon

LMR Partners’s Roivant Sciences ROIV Stock Holding History

LMR Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,000
Closed -$592K – 1601
2024
Q4 		$592K Sell
50,000
-300,000
-86% -$3.55M 0.01% 806
2024
Q3 		$4.04M Buy
350,000
+300,000
+600% +$3.42M 0.03% 419
2024
Q2 		$529K Buy
50,000
+34,800
+229% +$381K ﹤0.01% 761
2024
Q1 		$160K Buy
+15,200
New +$164K ﹤0.01% 890

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LMR Partners's ROIV Position: Q1 2026 in Review

LMR Partners held its Roivant Sciences (ROIV) position steady in Q1 2026 at 16,750 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

LMR Partners first reported a position in ROIV in Q1 2024 and has held it in 9 quarters since. The position peaked at $12.7M in Q2 2024. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • LMR Partners held 16,750 shares of Roivant Sciences worth $464K as of Q1 2026.
  • LMR Partners left its Roivant Sciences share count unchanged in Q1 2026.
  • Roivant Sciences made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1091 holding.
  • LMR Partners first reported a position in Roivant Sciences in Q1 2024 and has held it in 9 quarters since.
  • LMR Partners's Roivant Sciences position peaked at $12.7M in Q2 2024.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.